These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29937938)

  • 41. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
    Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of 11-DGA-3-
    Zhou L; Zou M; Zhu K; Ning S; Xia X
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31450608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Norcantharidin ameliorates proteinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy.
    Liu FY; Li Y; Peng YM; Ye K; Li J; Liu YH; Duan SB; Ling GH; Xu XQ; Zhou LT
    Am J Nephrol; 2008; 28(3):465-77. PubMed ID: 18176075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery.
    Deng L; Dong J; Wang W
    Mini Rev Med Chem; 2013 Jun; 13(8):1166-76. PubMed ID: 23373656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Norcantharidin Enhances the Antitumor Effect of 5-Fluorouracil by Inducing Apoptosis of Cervical Cancer Cells: Network Pharmacology, Molecular Docking, and Experimental Validation.
    Huang Y; Wan XW; Du YT; Feng Y; Yang LS; Liu YB; Chen T; Zhu Z; Xu YT; Wang CC
    Curr Issues Mol Biol; 2024 Apr; 46(5):3906-3918. PubMed ID: 38785510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Molecular mechanism of norcantharidin inducing apoptosis in liver cancer cells].
    Li GQ; Zhang SJ; Lü JF; Wu Y; Li J; Zhang G; Yu JT
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2145-8. PubMed ID: 21029633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways.
    An WW; Gong XF; Wang MW; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2004 Nov; 25(11):1502-8. PubMed ID: 15525474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
    Yu CC; Ko FY; Yu CS; Lin CC; Huang YP; Yang JS; Lin JP; Chung JG
    Int J Oncol; 2012 Sep; 41(3):1050-60. PubMed ID: 22684608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
    Xiong X; Wu M; Zhang H; Li J; Lu B; Guo Y; Zhou T; Guo H; Peng R; Li X; Tian Q; Wang Y
    Int J Oncol; 2015 Oct; 47(4):1321-8. PubMed ID: 26240015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells.
    Lee YC; Lee LM; Yang CH; Lin AM; Huang YC; Hsu CC; Chen MS; Chi CW; Yin PH; Kuo CD; Liao JF; Lee HC
    Oncol Rep; 2013 Jan; 29(1):237-43. PubMed ID: 23128522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells.
    Liu XH; Blazsek I; Comisso M; Legras S; Marion S; Quittet P; Anjo A; Wang GS; Misset JL
    Eur J Cancer; 1995 Jun; 31A(6):953-63. PubMed ID: 7646929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo.
    Li CC; Yu FS; Fan MJ; Chen YY; Lien JC; Chou YC; Lu HF; Tang NY; Peng SF; Huang WW; Chung JG
    Environ Toxicol; 2017 Mar; 32(3):723-738. PubMed ID: 27113412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preparation of the immunotoxin 2E8-norcantharidin and its targeting killing effect in vitro].
    Li LX; Tang YM; Zhang HZ; Shen HQ; Qian BQ; Luo CF
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):493-7. PubMed ID: 19099803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
    Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
    Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
    Lin CL; Chen CM; Lin CL; Cheng CW; Lee CH; Hsieh YH
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1867-1876. PubMed ID: 28760656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway.
    Xie X; Wu MY; Shou LM; Chen LP; Gong FR; Chen K; Li DM; Duan WM; Xie YF; Mao YX; Li W; Tao M
    Oncol Lett; 2015 Feb; 9(2):837-844. PubMed ID: 25624908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of norcantharidin on N-acetyltransferase activity in HepG2 cells.
    Wu LT; Chung JG; Chen JC; Tsauer W
    Am J Chin Med; 2001; 29(1):161-72. PubMed ID: 11321474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
    Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
    Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma.
    Yang H; Guo W; Xu B; Li M; Cui J
    Anticancer Drugs; 2007 Nov; 18(10):1133-7. PubMed ID: 17893513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
    Li M; Xu X; Lu F; Guo S
    Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.